Neuregulin4 Acts on Hypothalamic ErBb4 to Excite Oxytocin Neurons and Preserve Metabolic Homeostasis
Advanced Science · 2023
DOI: 10.1002/advs.202204824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Yi Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Centre for Diabetes, Shanghai Sixth People's Hospital Af…. Hauptthemen laut MEDLINE: Obesity, Oxytocin. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation of China, Shanghai Outstanding Academic Leaders, Shuguang Project.
Abstract (Originalsprache)
Neuregulin 4 (Nrg4) is an adipose tissue‐enriched secreted factor that modulates glucose and lipid metabolism. Nrg4 is closely associated with obesity and preserves diet‐induced metabolic disorders. However, the specific mechanisms via which Nrg4 regulates metabolic homeostasis remain incompletely understood. Here, this work finds that the Nrg4 receptor, ErbB4, is highly expressed in the hypothalamus, and the phosphorylation of hypothalamic ErbB4 is reduced in diet‐induced obesity (DIO) mice. Peripheral Nrg4 can act on ErbB4 via blood circulation and excite neurons in the paraventricular nucleus of hypothalamus (PVN). Central administration of recombinant Nrg4 protein (rNrg4) reduces obesity and related metabolic disorders by influencing energy expenditure and intake. Overexpression of ErbB4 in the PVN protects against obesity, whereas its knock down in oxytocin (Oxt) neuron accelerates obesity. Furthermore, Nrg4‐ErbB4 signaling excites Oxt release, and ablation of Oxt neuron considerably attenuates the effect of Nrg4 on energy balance. These data suggest that the hypothalamus is a key target of Nrg4, which partially explains the multifaceted roles of Nrg4 in metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Centre for Diabetes, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai…
- Institute for Metabolic Disease, Fengxian Central Hospital Affiliated to Southern Medical University, Shanghai, 201449, P. R. China.
- Department of Endocrinology, Affiliated Hospital of Nantong University, Nantong, 226001, P. R. China.
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, P. R. China.
ORCID-Profile: Cheng Hu
Förderung
- National Science Foundation of China
- Shanghai Outstanding Academic Leaders
- Shuguang Project
- Innovative research team of high-level local universities in Shanghai
- Major Natural Science Project of the Scientific Research and Innovation Plan of Shanghai Municipal Commission of Education
- Shanghai Research Center for Endocrine and Metabolic Diseases
- China Postdoctoral Science Foundation
- Shanghai Sixth People's Hospital Foundation
Zitieren
APA
Zhang, Y., Zhu, Y., Wang, J., Jin, L., Guo, M., Chen, L., Zhang, L., Li, Y., Wan, B., Zhang, R., Jia, W., & Hu, C. (2023). Neuregulin4 Acts on Hypothalamic ErBb4 to Excite Oxytocin Neurons and Preserve Metabolic Homeostasis. Advanced Science. https://doi.org/10.1002/advs.202204824
Vancouver
Zhang Y, Zhu Y, Wang J, Jin L, Guo M, Chen L, et al. Neuregulin4 Acts on Hypothalamic ErBb4 to Excite Oxytocin Neurons and Preserve Metabolic Homeostasis. Advanced Science. 2023. doi:10.1002/advs.202204824
BibTeX
@article{Zhang2023,
author = {Zhang, Yi and Zhu, Yangyang and Wang, Jinghui and Jin, Li and Guo, Mingwei and Chen, Liwei and Zhang, Lina and Li, Yangyang and Wan, Baocheng and Zhang, Rong and Jia, Weiping and Hu, Cheng},
title = {Neuregulin4 Acts on Hypothalamic ErBb4 to Excite Oxytocin Neurons and Preserve Metabolic Homeostasis},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202204824}
}
EUVIMED